Company / Operating Margin
NEUROONE MEDICAL TECHNOLOGIES Corp Operating Margin History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-344.3%
FY2025
5-year range
-5860.2% / -344.3%
FY2021-FY2025
Trend
+43.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin has fluctuated over the past 7 years, ranging from -5860.2% in FY2023 to -344.3% in FY2025.
Based on SEC 10-K filings.
-344.3% in FY2025 with a 10-year CAGR of +4301.8%.
Improved from -5860.2% to -344.3% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- +5391.6pp
- 5-Year Change
- -
- 10-Year Change
- +4301.8pp
Key checks
Key Insights
- In FY2025, operating margin increased 43.8% year-over-year.
- Lowest operating margin in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -2.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -344.3% | +43.8% |
| FY2024 | -612.3% | +89.6% |
| FY2023 | -5860.2% | -2.2% |
| FY2022 | -5735.9% | -108.4% |
| FY2021 | -2751.8% | - |
| FY2016 | - | - |
| FY2015 | -4646.1% | -131.3% |
| FY2014 | -2009.0% | - |
| FY2012 | - | - |
| FY2011 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026